Myths & Truths on Women and হৃদয় Disease
link
MYTH #1: Most women in America die from cancer.
TRUTH: হৃদয় disease is the leading cause of death of women in the U.S. Almost every minute, a woman in the U.S. dies from হৃদয় disease. Nearly five times as many women (200,000) will die from হৃদয় attacks alone this বছর than will die from breast cancer.[1]
MYTH #2: হৃদয় disease is a man’s problem.
TRUTH: Since 1984, আরো women than men have died of হৃদয় disease each year. Women have a 28% increased risk of dying as compared to men to die within the first বছর after a হৃদয় attack.[1]
MYTH #3: Only older women have হৃদয় disease.
TRUTH: হৃদয় disease threatens all women, even those as young as 30 and 40.For example, the rate of sudden cardiac death of women in their 30s and 40s is increasing much faster than in men their same age—rising 21 percent in the 1990s.[2]
MYTH #4: Most doctors know about women’s risk of হৃদয় disease.
TRUTH: A 2005 American হৃদয় Association study showed that only eight percent of primary care physicians and 17 percent of cardiologists knew that হৃদয় disease kills আরো women than men.[3]
MYTH #5: Women’s and men’s হৃদয় disease is the same and should be treated the same.
TRUTH: In many cases, the experts don’t know. The vast majority of cardiovascular research has been performed on men and/or data have not been separated out based on gender. Where men and women have been studied separately, some important differences have been identified. As importantly, however, women should be treated as aggressively as men when there is proof of benefit, such as using statins and aspirin after a হৃদয় attack.
MYTH #6: Women and men with হৃদয় disease get the same care.
TRUTH: Far too often, women fighting হৃদয় disease are not accurately diagnosed and do not receive the care they need when they need it. A study published in the January, 2009 issue of the journal হৃদয় showed that among হৃদয় patients, women were less likely than men to receive medications called beta blockers, statins and ACE inhibitors—which are crucial to prevent further হৃদয় problems.[5] Women are also less likely to receive ICDs (an implantable cardioverter defibrillator, a device that helps to control irregular heartbeats) অথবা even aspirin, following a diagnosis of হৃদয় disease.[5] Even newer studies নিশ্চিত the disparities in care and treatment between men and women.[4,5]
MYTH #7: If হৃদয় disease isn’t in your family, it isn’t your problem.
TRUTH: A family history of হৃদয় disease does increase risk of developing the disease. But many women without a family history have হৃদয় attacks অথবা হৃদয় problems. High blood-pressure, high cholesterol, diabetes, kidney disease, poor dietary patterns, high sodium intake, smoking, being overweight অথবা obese, and physical inactivity, all factors that increase your risk of হৃদয় disease.
MYTH #8: আপনি can’t do anything to stop হৃদয় disease.
TRUTH: Yes, আপনি can! আপনি can significantly reduce your risk of হৃদয় disease if আপনি have the information আপনি need, know the প্রশ্ন to ask your health provider and have the support to make heart-smart changes in your life. Visit our Prevention & Early Detection for আরো information.
1. Lloyd-Jones D, Adams R, Brown T,. et al. হৃদয় Disease and Stroke Statistics 2010 Update: A প্রতিবেদন From the American হৃদয় Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2010;121:e1-e170.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GH. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158–63.
3.Mosca L, Linfante LH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499–510.
4. Dey S, Flather, MD, Breiger D, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95(1):20-6.
5. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death. JAMA. 2007;298(13):1517-1524.
link
MYTH #1: Most women in America die from cancer.
TRUTH: হৃদয় disease is the leading cause of death of women in the U.S. Almost every minute, a woman in the U.S. dies from হৃদয় disease. Nearly five times as many women (200,000) will die from হৃদয় attacks alone this বছর than will die from breast cancer.[1]
MYTH #2: হৃদয় disease is a man’s problem.
TRUTH: Since 1984, আরো women than men have died of হৃদয় disease each year. Women have a 28% increased risk of dying as compared to men to die within the first বছর after a হৃদয় attack.[1]
MYTH #3: Only older women have হৃদয় disease.
TRUTH: হৃদয় disease threatens all women, even those as young as 30 and 40.For example, the rate of sudden cardiac death of women in their 30s and 40s is increasing much faster than in men their same age—rising 21 percent in the 1990s.[2]
MYTH #4: Most doctors know about women’s risk of হৃদয় disease.
TRUTH: A 2005 American হৃদয় Association study showed that only eight percent of primary care physicians and 17 percent of cardiologists knew that হৃদয় disease kills আরো women than men.[3]
MYTH #5: Women’s and men’s হৃদয় disease is the same and should be treated the same.
TRUTH: In many cases, the experts don’t know. The vast majority of cardiovascular research has been performed on men and/or data have not been separated out based on gender. Where men and women have been studied separately, some important differences have been identified. As importantly, however, women should be treated as aggressively as men when there is proof of benefit, such as using statins and aspirin after a হৃদয় attack.
MYTH #6: Women and men with হৃদয় disease get the same care.
TRUTH: Far too often, women fighting হৃদয় disease are not accurately diagnosed and do not receive the care they need when they need it. A study published in the January, 2009 issue of the journal হৃদয় showed that among হৃদয় patients, women were less likely than men to receive medications called beta blockers, statins and ACE inhibitors—which are crucial to prevent further হৃদয় problems.[5] Women are also less likely to receive ICDs (an implantable cardioverter defibrillator, a device that helps to control irregular heartbeats) অথবা even aspirin, following a diagnosis of হৃদয় disease.[5] Even newer studies নিশ্চিত the disparities in care and treatment between men and women.[4,5]
MYTH #7: If হৃদয় disease isn’t in your family, it isn’t your problem.
TRUTH: A family history of হৃদয় disease does increase risk of developing the disease. But many women without a family history have হৃদয় attacks অথবা হৃদয় problems. High blood-pressure, high cholesterol, diabetes, kidney disease, poor dietary patterns, high sodium intake, smoking, being overweight অথবা obese, and physical inactivity, all factors that increase your risk of হৃদয় disease.
MYTH #8: আপনি can’t do anything to stop হৃদয় disease.
TRUTH: Yes, আপনি can! আপনি can significantly reduce your risk of হৃদয় disease if আপনি have the information আপনি need, know the প্রশ্ন to ask your health provider and have the support to make heart-smart changes in your life. Visit our Prevention & Early Detection for আরো information.
1. Lloyd-Jones D, Adams R, Brown T,. et al. হৃদয় Disease and Stroke Statistics 2010 Update: A প্রতিবেদন From the American হৃদয় Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2010;121:e1-e170.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GH. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104:2158–63.
3.Mosca L, Linfante LH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111:499–510.
4. Dey S, Flather, MD, Breiger D, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95(1):20-6.
5. Curtis LH, Al-Khatib SM, Shea AM, et al. Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death. JAMA. 2007;298(13):1517-1524.
